Blockade of the CD47/SIRPα Checkpoint Potentiates the Anti-Tumor Efficacy of Tafasitamab

被引：3
|
作者：
Mangelberger, Doris
Augsberger, Christian
Landgraf, Karin
Heitmuller, Christina
Steidl, Stefan
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab
    Biedermann, Alexander
    Patra-Kneuer, Maria
    Mougiakakos, Dimitrios
    Buettner-Herold, Maike
    Mangelberger-Eberl, Doris
    Berges, Johannes
    Kellner, Christian
    Altmeyer, Sarah
    Bittenbring, Jorg Thomas
    Augsberger, Christian
    Ilieva-Babinsky, Kristina
    Haskamp, Stefan
    Beier, Fabian
    Lischer, Christopher
    Vera, Julio
    Luehrmann, Anja
    Bertz, Simone
    Voelkl, Simon
    Jacobs, Benedikt
    Steidl, Stefan
    Mackensen, Andreas
    Bruns, Heiko
    HAEMATOLOGICA, 2024, 109 (12) : 3928 - 3940
  • [2] Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
    Zhang, Wenting
    Huang, Qinghua
    Xiao, Weiwei
    Zhao, Yue
    Pi, Jiang
    Xu, Huan
    Zhao, Hongxia
    Xu, Junfa
    Evans, Colin E.
    Jin, Hua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [3] SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
    Veillette, Andre
    Chen, Jun
    TRENDS IN IMMUNOLOGY, 2018, 39 (03) : 173 - 184
  • [4] Blockade of SIRPα-CD47 axis by anti-SIRPα antibody enhances anti-tumor activity of DXd antibody-drug conjugates
    Sue, Mayumi
    Tsubaki, Takuya
    Ishimoto, Yoko
    Hayashi, Shinko
    Ishida, Saori
    Otsuka, Takafumi
    Isumi, Yoshitaka
    Kawase, Yumi
    Yamaguchi, Junko
    Nakada, Takashi
    Ishiguro, Jun
    Nakamura, Kensuke
    Kawaida, Reimi
    Ohtsuka, Toshiaki
    Wada, Teiji
    Agatsuma, Toshinori
    Kawasaki, Norihito
    PLOS ONE, 2024, 19 (06):
  • [5] CD47 BLOCKADE SYNERGIZES WITH PD-1 CHECKPOINT INHIBITOR AND ENHANCES ANTI-TUMOR EFFICACY IN HEPATOCELLULAR CARCINOMA
    Kang, Wonseok
    Kim, Ji-Young
    Yang, Sera
    Kang, Sohee
    Paik, Yong-Han
    HEPATOLOGY, 2019, 70 : 1199A - 1200A
  • [6] SIRP? DEFICIENT CAR-MACROPHAGES EXHIBIT ENHANCED ANTI-TUMOR FUNCTION AND BYPASS THE CD47 IMMUNE CHECKPOINT
    Sloas, Chris
    Gabbasov, Rashid
    Anderson, Nicholas
    Abramson, Sascha
    Klichinsky, Michael
    Ohtani, Yumi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A152 - A152
  • [7] CD47 blockade to enhance adaptive anti-tumor immune responses
    Anderson, Katie L.
    Ito, Daisuke
    Lins, Debra C.
    Curtsinger, Julie M.
    Mescher, Matthew F.
    Modiano, Jaime F.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Tumor-selective Blockade of CD47 Signaling with CD47 Antibody for Enhanced Anti-tumor Activity in Malignant Meningioma
    Liu, Xiaotong
    Zhang, Huarong
    Wang, Chaohu
    Li, Zhiyong
    Zhu, Qianchao
    Feng, Yiwen
    Fan, Jun
    Qi, Songtao
    Wu, Zhiyong
    Liu, Yi
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (10) : 2159 - 2173
  • [9] The SIRPα-CD47 immune checkpoint in NK cells
    Deuse, Tobias
    Hu, Xiaomeng
    Agbor-Enoh, Sean
    Jang, Moon K.
    Alawi, Malik
    Saygi, Ceren
    Gravina, Alessia
    Tediashvili, Grigol
    Nguyen, Vinh Q.
    Liu, Yuan
    Valantine, Hannah
    Lanier, Lewis L.
    Schrepfer, Sonja
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (03):
  • [10] Blockade of CD47 or SIRPα: a new cancer immunotherapy
    Murata, Yoji
    Saito, Yasuyuki
    Kotani, Takenori
    Matozaki, Takashi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (10) : 945 - 951
12345